Remove Heart attacks Remove Peripheral Arterial Disease Remove Thrombolysis
article thumbnail

Inclusivity in randomised clinical trials: myth or reality?

Heart BMJ

The study aims to evaluate the applicability in the real world of randomised clinical trials (RCT) on antithrombotic treatment in patients with cardiovascular disease (CVD) and peripheral artery disease (PAD).

article thumbnail

Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease

Heart BMJ

Methods Inclusion and exclusion criteria of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS), Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA), Prevention of Cardiovascular events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background (..)